Early clinical response after 2 weeks of sorafenib therapy predicts outcomes and anti-tumor response in patients with advanced hepatocellular carcinoma
- Teiji Kuzuya
- , Masatoshi Ishigami
- , Yoji Ishizu
- , Takashi Honda
- , Kazuhiko Hayashi
- , Yoshiaki Katano
- , Yoshiki Hirooka
- , Tetsuya Ishikawa
- , Isao Nakano
- , Hidemi Goto
研究成果: ジャーナルへの寄稿 › 学術論文 › 査読
35
被引用数
(Scopus)